0001171843-24-001304.txt : 20240312
0001171843-24-001304.hdr.sgml : 20240312
20240312200128
ACCESSION NUMBER: 0001171843-24-001304
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240311
FILED AS OF DATE: 20240312
DATE AS OF CHANGE: 20240312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Levitz Michael L
CENTRAL INDEX KEY: 0001468019
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14027
FILM NUMBER: 24744152
MAIL ADDRESS:
STREET 1: C/O ANALOGIC CORPORATION
STREET 2: 8 CENTENNIAL DRIVE
CITY: PEABODY
STATE: MA
ZIP: 01960
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anika Therapeutics, Inc.
CENTRAL INDEX KEY: 0000898437
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 043145961
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: (781) 457-9000
MAIL ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC
DATE OF NAME CHANGE: 19970114
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA RESEARCH INC
DATE OF NAME CHANGE: 19930309
4
1
ownership.xml
X0508
4
2024-03-11
0
0000898437
Anika Therapeutics, Inc.
ANIK
0001468019
Levitz Michael L
32 WIGGINS AVENUE
BEDFORD
MA
01730
0
1
0
0
EVP, CFO, Treasurer
0
Common Stock
2024-03-11
4
M
0
4438
0
A
37830
D
Common Stock
2024-03-11
4
F
0
1303
25.42
D
36527
D
Common Stock
2024-03-11
4
M
0
5875
0
A
42402
D
Common Stock
2024-03-11
4
F
0
1725
25.42
D
40677
D
Common Stock
2024-03-11
4
M
0
8888
0
A
49565
D
Common Stock
2024-03-11
4
F
0
2610
25.79
D
46955
D
Restricted Stock Unit
0.00
2024-03-11
4
M
0
4438
0
D
Common Stock
4438
0
D
Restricted Stock Unit
0.00
2024-03-11
4
M
0
5875
0
D
Common Stock
5875
11749
D
Restricted Stock Unit
0.00
2024-03-11
4
M
0
8888
0
D
Common Stock
8888
8888
D
Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021.
Includes 160 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on November 14, 2023.
Reflects an aggregate of 1,303 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024.
Reflects the closing price of ANIK common stock on March 8, 2024, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations.
Reflects the first vesting installment of RSUs granted on March 9, 2023.
Reflects an aggregate of 1,725 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024.
Reflects the second vesting installment of RSUs granted on March 11, 2022.
Reflects an aggregate of 2,610 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2024.
Reflects the closing price of ANIK common stock on March 11, 2024, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022.
Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024.
Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023.
/s/ Michael L. Levitz
2024-03-12